Process Development

KBI Biopharma delivers end-to-end process development services for both mammalian and microbial-based biologics, enabling efficient scale-up and robust transfer to cGMP manufacturing. Our team supports the full development cycle, from early-stage feasibility and small-scale protein production through upstream and downstream process optimization, characterization, and scale-down validation studies. With expertise spanning CHO and E. coli platforms, KBI Biopharma helps clients address molecule-specific challenges while reducing development timelines and cost. Our integrated approach combines scientific rigor, flexible project execution, and deep biologics experience to ensure high-yield, high-quality processes that are ready for GMP manufacturing and regulatory expectations. Whether optimizing legacy processes or developing new ones from scratch, KBI is the partner of choice for biopharma innovators.